Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...

Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

The actress and entertainment personality partnered with Amgen to share candid glimpses of how she lives with her medical ...

InnoCare Pharma has announced that its Phase II study of the TYK2 inhibitor ICP-488 for psoriasis treatment met the primary ...

This chronic condition that affects millions is often misunderstood or underappreciated in terms of its broader impact.

PRNewswire Ahmedabad Gujarat [India] October 14 Accord BioPharma Inc the US specialty division of Intas Pharmaceuticals Ltd ...

InnoCare Pharma’s tyrosine kinase 2 (TYK2) inhibitor has hit the main goals of a phase 2 trial in China, sustaining the ...

These 28-week data on twice-daily ESK-001 highlight the drug’s safety and efficacy among patients with psoriasis.

Your doctor will want to know your medical history ... which will require long-term treatment. Guttate psoriasis can emerge temporarily and often goes away on its own. But it’s good to get ...

Psoriasis is a multifactorial immune-mediated inflammatory disease. Its pathogenesis involves abnormal accumulation of neutrophils and T-cell related abnormalities. Pyroptosis is a type of regulated ...

The first speaker at this seminar was Dr. Nobuhiro Nouchi from the Nouchi Dermatology Clinic in Japan who discussed the successful treatment of vitiligo and alopecia areata with the Company’s XTRAC ® ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that phase II clinical study results of ...